Diabetic Foot Treatment (Heberprot-P)
Groundbreaking growth factor therapy reducing amputation risk.
About this Treatment
Heberprot-P is Cuba's groundbreaking recombinant human epidermal growth factor therapy, injected directly into diabetic foot ulcers to accelerate healing and dramatically reduce amputation rates. Recognized internationally, it has transformed diabetic foot care and is used in dozens of countries. The treatment is administered by specialists in wound-care centers.
Symptoms
Non-healing foot ulcers; deep or infected wounds; tissue necrosis; peripheral neuropathy (numbness, tingling); reduced blood flow to feet; callus formation over pressure points; signs of infection (redness, pus, odor).
Treatment Benefits
Significant reduction in major amputations; accelerates healing of chronic ulcers; treats complex and deep wounds; evidence-based, internationally used; improves quality of life; cost-effective versus amputation and long-term wound care.
Candidate Criteria
Adults with diabetes and non-healing foot ulcers (typically >grade 2 Wagner); adequate blood supply to the foot (vascular assessment); no uncontrolled infection requiring immediate surgery. Vascular status and wound photos required.
Procedure Overview
1) Wound assessment and grading. 2) Vascular evaluation of the limb. 3) Surgical debridement of dead tissue. 4) Intralesional injection of Heberprot-P (75 µg) every other day. 5) Advanced wound dressings and offloading. 6. Treatment of infection if present. 7) Monitoring until granulation and closure.
Recovery Timeline
Treatment course 5–8 weeks; wound closure typically achieved within 6–12 weeks depending on ulcer depth and patient health; ongoing diabetic management essential.
Risks & Considerations
Local pain at injection site; infection if wound care inadequate; treatment failure in severely ischemic limbs; hypoglycemia management needs attention.
Aftercare & Follow-up
Continued wound care and dressings; diabetic foot care education; proper footwear and offloading; glycemic control support; regular foot examinations; lifestyle guidance.
Your Patient Journey
- 1
Consultation
- 2
Wound Assessment
- 3
Vascular Evaluation
- 4
Debridement
- 5
Heberprot-P Injections
- 6
Wound Monitoring
- 7
Closure & Education
Treatment Centers Offering this Care
Why Choose Cuba for Diabetic Foot Treatment (Heberprot-P)
Internationally recognized biotechnology
Cuba pioneered breakthroughs like Heberprot-P®, used worldwide for diabetic foot ulcers.
Highly experienced specialists
Board-certified doctors trained in Cuba's acclaimed medical education system.
Affordable all-inclusive packages
From $3,500 (treatment course, all-inclusive)
Personalized patient support
Dedicated coordinators assist you from first inquiry through recovery.
Related Treatments
Frequently Asked Questions
Common questions from patients considering this treatment. Still unsure? Contact our team anytime.